As of today (2024-04-24), Assertio Holdings's share price is $0.86. Assertio Holdings's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $0.28. Hence, Assertio Holdings's Price to Tangible Book Ratio of today is 3.05.
The historical rank and industry rank for Assertio Holdings's Price-to-Tangible-Book or its related term are showing as below:
ASRT'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 3.04 Med: 3.79 Max: 7.49
Current: 3.07
During the past 13 years, Assertio Holdings's highest Price to Tangible Book Ratio was 7.49. The lowest was 3.04. And the median was 3.79.
ASRT's Price-to-Tangible-Book is ranked worse than 64.95% of 873
companies
in the Drug Manufacturers industry
Industry Median: 2.32
vs ASRT: 3.07
A closely related ratio is called PB Ratio. As of today, Assertio Holdings's share price is $0.86. Assertio Holdings's Book Value per Sharefor the quarter that ended in Dec. 2023 was $1.46. Hence, Assertio Holdings's P/B Ratio of today is 0.59.
Assertio Holdings Price-to-Tangible-Book Historical Data
The historical data trend for Assertio Holdings's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Assertio Holdings's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Assertio Holdings Price-to-Tangible-Book Distribution
For the Drug Manufacturers industry and Healthcare sector, Assertio Holdings's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Assertio Holdings's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Assertio Holdings Price-to-Tangible-Book Related Terms
Thank you for viewing the detailed overview of Assertio Holdings's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
Assertio Holdings (Assertio Holdings) Business Description
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults 18 years of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASRT has been successfully added to your 